ArticleNature communications2021

Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML.

Toshihiko Oki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.